ITTO20110638A1 - PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES - Google Patents
PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATESInfo
- Publication number
- ITTO20110638A1 ITTO20110638A1 IT000638A ITTO20110638A ITTO20110638A1 IT TO20110638 A1 ITTO20110638 A1 IT TO20110638A1 IT 000638 A IT000638 A IT 000638A IT TO20110638 A ITTO20110638 A IT TO20110638A IT TO20110638 A1 ITTO20110638 A1 IT TO20110638A1
- Authority
- IT
- Italy
- Prior art keywords
- pathologies
- pathological states
- methods
- combination
- pharmaceutical composition
- Prior art date
Links
- 230000001575 pathological effect Effects 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010130352/15A RU2528093C2 (en) | 2010-07-21 | 2010-07-21 | Pharmaceutical composition and method of treating acute and chronic respiratory diseases and cough syndrome |
RU2011125992/15A RU2529783C2 (en) | 2011-06-24 | 2011-06-24 | Medication for treating pathological syndrome and method of treating acute and chronic respiratory system diseases and cough synrdome |
Publications (1)
Publication Number | Publication Date |
---|---|
ITTO20110638A1 true ITTO20110638A1 (en) | 2012-01-22 |
Family
ID=44899162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000638A ITTO20110638A1 (en) | 2010-07-21 | 2011-07-15 | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES |
Country Status (21)
Country | Link |
---|---|
US (2) | US8795657B2 (en) |
EP (1) | EP2595655A2 (en) |
JP (2) | JP2013533269A (en) |
CN (1) | CN103200964A (en) |
AR (1) | AR082313A1 (en) |
AU (1) | AU2011281247B2 (en) |
BR (1) | BR112013001297A2 (en) |
CA (1) | CA2805978C (en) |
CL (1) | CL2013000202A1 (en) |
DE (1) | DE112011102412T5 (en) |
EA (1) | EA029228B1 (en) |
ES (1) | ES2425315R1 (en) |
FR (1) | FR2962909A1 (en) |
GB (1) | GB2496800B (en) |
IT (1) | ITTO20110638A1 (en) |
MX (1) | MX356678B (en) |
MY (1) | MY158522A (en) |
NZ (1) | NZ606977A (en) |
PE (1) | PE20130387A1 (en) |
SG (1) | SG187579A1 (en) |
WO (1) | WO2012010973A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181297C2 (en) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Method of treatment of pathological syndrome and medicinal agent |
RU2309732C1 (en) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation |
NZ606767A (en) | 2010-07-15 | 2015-08-28 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
EP2593474A2 (en) | 2010-07-15 | 2013-05-22 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
CN103124741A (en) * | 2010-07-21 | 2013-05-29 | 奥列格·伊里奇·爱泼斯坦 | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
ITTO20110638A1 (en) * | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES |
PE20130815A1 (en) * | 2010-07-21 | 2013-07-18 | Oleg Iliich Epshtein | A COMPOSITION OF PHARMACEUTICAL COMBINATION AND METHODS TO TREAT DIABETES AND METABOLIC DISORDERS |
CN103119061A (en) | 2010-07-21 | 2013-05-22 | 奥列格·伊里奇·爱泼斯坦 | A method of treating attention deficit hyperactivity disorder |
SG10201403870XA (en) * | 2010-08-06 | 2014-08-28 | Oleg Iliich Epshtein | Combination Pharmaceutical Composition And Methods Of Treating And Preventing The Infectious Diseases |
RU2013111961A (en) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | METHOD FOR DETERMINING THE EXPRESSION OF MODIFICATION ACTIVITY ASSOCIATED WITH A CARRIER |
RU2013111962A (en) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | METHOD FOR DETERMINING THE EXPRESSION OF MODIFICATION ACTIVITY ASSOCIATED WITH A CARRIER |
DE102020007979A1 (en) | 2020-12-29 | 2022-06-30 | Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie | Composition for treating coronavirus infections |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
WO1994008619A1 (en) | 1992-10-08 | 1994-04-28 | The Kennedy Institute Of Rheumatology | Treatment of autoimmune and inflammatory disorders |
IT1261849B (en) | 1993-09-02 | 1996-06-03 | Avantgarde Spa | MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR VERY LOW DOSAGE DRUGS, IN PARTICULAR HOMEOPATHIC DRUGS. |
US5629286A (en) | 1994-03-31 | 1997-05-13 | Brewitt; Barbara | Homeopathic dilutions of growth factors |
IL110035A0 (en) | 1994-06-16 | 1994-10-07 | Tapuach Natural Technologies 1 | Homeopathic formulations |
CA2251617A1 (en) | 1996-02-12 | 1997-08-14 | Oleg Iliich Epshtein | Medicament and method of treating an organism with medicaments |
US5834443A (en) * | 1996-05-21 | 1998-11-10 | Masiello; Domenick J. | Composition and method for treating herpes simplex |
RU2114646C1 (en) | 1996-09-30 | 1998-07-10 | Олег Ильич Эпштейн | Method of enhancement of organism protective property at effect of external physical factors |
RU2103999C1 (en) | 1997-01-31 | 1998-02-10 | Олег Ильич Эпштейн | Method of alcoholism treatment |
RU2181297C2 (en) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Method of treatment of pathological syndrome and medicinal agent |
RU2199244C2 (en) * | 2000-10-05 | 2003-02-27 | Самофалова Лариса Александровна | Method of producing food flour from oil-bearing seeds |
RU2191602C1 (en) | 2001-06-01 | 2002-10-27 | Эпштейн Олег Ильич | Medicinal agent and method of treatment of allergic and pseudoallergic responses |
RU2197266C1 (en) * | 2001-06-01 | 2003-01-27 | Эпштейн Олег Ильич | Medicinal agent and method of treatment of erosive and inflammatory diseases of gastroenteric tract |
RU2206338C1 (en) | 2001-12-07 | 2003-06-20 | Эпштейн Олег Ильич | Method of cough syndrome treatment |
RU2199344C1 (en) | 2001-12-07 | 2003-02-27 | Эпштейн Олег Ильич | Medicinal agent and method of treatment of cough syndrome |
RU2209083C1 (en) | 2001-12-26 | 2003-07-27 | Эпштейн Олег Ильич | Medicament and method for treating cough |
RU2201255C1 (en) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Medicinal agent and method of regulation of vascular tonus |
RU2199345C1 (en) | 2001-12-26 | 2003-02-27 | Эпштейн Олег Ильич | Medicinal agent and method of regulation of carbohydrate and lipid metabolism |
UA76641C2 (en) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Homeopathic medicinal agent and method for curing diseases of prostate |
UA76639C2 (en) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Homeopathic medication and method for treating erectile dysfunctions |
UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
CN101107003B (en) | 2003-03-14 | 2012-08-08 | 营养学研究有限公司 | Homeopathic formulations useful for treating pain and/or inflammation |
RU2253478C1 (en) | 2003-10-01 | 2005-06-10 | Эпштейн Олег Ильич | Agent for potentiation therapeutical effects: enhancing effect of drug |
AU2007261782A1 (en) * | 2006-06-06 | 2007-12-27 | Oleg Iliich Epshtein | Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
JP2011518876A (en) * | 2008-04-29 | 2011-06-30 | ガンヴァント、 デビチャンド オスワル、 | Homeopathic formulation |
SE1350179A1 (en) * | 2010-07-15 | 2013-04-12 | Oleg Iliich Epshtein | Pharmaceutical compositions and treatment methods |
EP2593474A2 (en) | 2010-07-15 | 2013-05-22 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
WO2012007839A2 (en) | 2010-07-15 | 2012-01-19 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
DE112011102350T5 (en) | 2010-07-15 | 2013-04-18 | Oleg Iliich Epshtein | A combination pharmaceutical composition and method for treating disorders of the genitourinary system |
ITTO20110638A1 (en) * | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES |
PE20130815A1 (en) | 2010-07-21 | 2013-07-18 | Oleg Iliich Epshtein | A COMPOSITION OF PHARMACEUTICAL COMBINATION AND METHODS TO TREAT DIABETES AND METABOLIC DISORDERS |
CN103124741A (en) | 2010-07-21 | 2013-05-29 | 奥列格·伊里奇·爱泼斯坦 | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
SG10201403870XA (en) | 2010-08-06 | 2014-08-28 | Oleg Iliich Epshtein | Combination Pharmaceutical Composition And Methods Of Treating And Preventing The Infectious Diseases |
-
2011
- 2011-07-15 IT IT000638A patent/ITTO20110638A1/en unknown
- 2011-07-15 MY MYPI2013000232A patent/MY158522A/en unknown
- 2011-07-15 ES ES201390008A patent/ES2425315R1/en active Pending
- 2011-07-15 JP JP2013520239A patent/JP2013533269A/en active Pending
- 2011-07-15 DE DE112011102412T patent/DE112011102412T5/en not_active Withdrawn
- 2011-07-15 MX MX2013000806A patent/MX356678B/en active IP Right Grant
- 2011-07-15 BR BR112013001297A patent/BR112013001297A2/en not_active Application Discontinuation
- 2011-07-15 US US13/135,884 patent/US8795657B2/en active Active
- 2011-07-15 CA CA2805978A patent/CA2805978C/en not_active Expired - Fee Related
- 2011-07-15 EA EA201300131A patent/EA029228B1/en not_active IP Right Cessation
- 2011-07-15 NZ NZ606977A patent/NZ606977A/en not_active IP Right Cessation
- 2011-07-15 FR FR1156475A patent/FR2962909A1/en not_active Withdrawn
- 2011-07-15 SG SG2013004825A patent/SG187579A1/en unknown
- 2011-07-15 WO PCT/IB2011/002346 patent/WO2012010973A2/en active Application Filing
- 2011-07-15 CN CN2011800455711A patent/CN103200964A/en active Pending
- 2011-07-15 AU AU2011281247A patent/AU2011281247B2/en not_active Ceased
- 2011-07-15 EP EP11778681.4A patent/EP2595655A2/en not_active Ceased
- 2011-07-15 GB GB1302926.9A patent/GB2496800B/en not_active Expired - Fee Related
- 2011-07-15 PE PE2013000107A patent/PE20130387A1/en not_active Application Discontinuation
- 2011-07-21 AR ARP110102643A patent/AR082313A1/en unknown
-
2013
- 2013-01-21 CL CL2013000202A patent/CL2013000202A1/en unknown
-
2014
- 2014-07-11 US US14/328,792 patent/US20150023985A1/en not_active Abandoned
-
2016
- 2016-07-01 JP JP2016131753A patent/JP2016216479A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
SG187579A1 (en) | 2013-03-28 |
US20150023985A1 (en) | 2015-01-22 |
EA029228B1 (en) | 2018-02-28 |
MX2013000806A (en) | 2013-10-28 |
JP2013533269A (en) | 2013-08-22 |
NZ606977A (en) | 2015-08-28 |
GB2496800A (en) | 2013-05-22 |
MX356678B (en) | 2018-06-08 |
CL2013000202A1 (en) | 2015-01-16 |
WO2012010973A2 (en) | 2012-01-26 |
ES2425315R1 (en) | 2014-09-08 |
GB2496800B (en) | 2018-05-23 |
US20120225074A1 (en) | 2012-09-06 |
ES2425315A2 (en) | 2013-10-14 |
FR2962909A1 (en) | 2012-01-27 |
JP2016216479A (en) | 2016-12-22 |
CA2805978C (en) | 2016-06-28 |
EP2595655A2 (en) | 2013-05-29 |
AU2011281247A1 (en) | 2013-03-14 |
EA201300131A1 (en) | 2013-11-29 |
US8795657B2 (en) | 2014-08-05 |
AU2011281247B2 (en) | 2015-07-30 |
CA2805978A1 (en) | 2012-01-26 |
MY158522A (en) | 2016-10-14 |
CN103200964A (en) | 2013-07-10 |
PE20130387A1 (en) | 2013-03-30 |
DE112011102412T5 (en) | 2013-07-04 |
GB201302926D0 (en) | 2013-04-03 |
AR082313A1 (en) | 2012-11-28 |
BR112013001297A2 (en) | 2017-11-21 |
WO2012010973A3 (en) | 2012-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITTO20110638A1 (en) | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES | |
BR112013009069A2 (en) | patient-attached instrumentation and methods | |
HK1167869A1 (en) | Nanoscale platinum compounds and methods of use thereof | |
BR112013023776A2 (en) | composition and seal-sealed opening | |
BR112012000568A2 (en) | multiple sclerosis treatment with laquinimod | |
BR112012004979A2 (en) | seed treatment compositions and methods | |
BR112012017441A2 (en) | compounds and methods | |
BRPI0912123A2 (en) | Salt compositions and production methods thereof | |
ITTO20110628A1 (en) | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING FUNCTIONAL DISORDERS OR PATHOLOGICAL STATES OF THE GASTROINTESTINAL TRACT | |
IL223286A0 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
ITTO20110641A1 (en) | PHARMACEUTICAL COMPOSITIONS AND TREATMENT METHODS | |
BR112014006291A2 (en) | composition and use of composition | |
BR112014005660A2 (en) | coated implants and related methods | |
FI20105414A0 (en) | Method and arrangement for preventing structure movement | |
ITTO20110640A1 (en) | PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM | |
FI20090142A0 (en) | New methods and products | |
NO20092615A1 (en) | Computer-implemented early dropping | |
SMT201600041B (en) | THERAPEUTIC AGENTS 713 | |
BR112013014915A2 (en) | curative composition and treatment methods | |
EP2707486A4 (en) | Diagnosis and treatment of friedreich's ataxia | |
SG10201510568WA (en) | Novel 19-nor-steroids and their use for treating progesterone-dependent conditions | |
EP2729155A4 (en) | Methods of treating or preventing rheumatic disease | |
BR112013009075A2 (en) | method and arrangement for pulp treatment | |
FI20106078A0 (en) | Treatment of fibrous fraction | |
PL2609925T3 (en) | Dermatan sulfate for use in the treatment of pathologies wherein metalloproteinases are involved |